156 related articles for article (PubMed ID: 37332337)
1. Fenofibrate attenuates the cytotoxic effect of cisplatin on lung cancer cells by enhancing the antioxidant defense system
Kogami M; Abe S; Nakamura H; Aoshiba K
Oncol Lett; 2023 Jul; 26(1):313. PubMed ID: 37332337
[TBL] [Abstract][Full Text] [Related]
2. Fenofibrate decreases radiation sensitivity via peroxisome proliferator-activated receptor α-mediated superoxide dismutase induction in HeLa cells.
Liu X; Jang SS; An Z; Song H; Kim WD; Yu JR; Park WY
Radiat Oncol J; 2012 Jun; 30(2):88-95. PubMed ID: 22984687
[TBL] [Abstract][Full Text] [Related]
3. Up-regulation of Nrf2 is involved in FGF21-mediated fenofibrate protection against type 1 diabetic nephropathy.
Cheng Y; Zhang J; Guo W; Li F; Sun W; Chen J; Zhang C; Lu X; Tan Y; Feng W; Fu Y; Liu GC; Xu Z; Cai L
Free Radic Biol Med; 2016 Apr; 93():94-109. PubMed ID: 26849944
[TBL] [Abstract][Full Text] [Related]
4. The Role of Akt2 in the Protective Effect of Fenofibrate against Diabetic Nephropathy.
Cheng Y; Zhang X; Ma F; Sun W; Wang W; Yu J; Shi Y; Cai L; Xu Z
Int J Biol Sci; 2020; 16(4):553-567. PubMed ID: 32025205
[TBL] [Abstract][Full Text] [Related]
5. Fenofibrate inhibits endothelin-1 expression by peroxisome proliferator-activated receptor α-dependent and independent mechanisms in human endothelial cells.
Glineur C; Gross B; Neve B; Rommens C; Chew GT; Martin-Nizard F; Rodríguez-Pascual F; Lamas S; Watts GF; Staels B
Arterioscler Thromb Vasc Biol; 2013 Mar; 33(3):621-8. PubMed ID: 23329136
[TBL] [Abstract][Full Text] [Related]
6. Aldo-keto reductase 1B10 promotes development of cisplatin resistance in gastrointestinal cancer cells through down-regulating peroxisome proliferator-activated receptor-γ-dependent mechanism.
Matsunaga T; Suzuki A; Kezuka C; Okumura N; Iguchi K; Inoue I; Soda M; Endo S; El-Kabbani O; Hara A; Ikari A
Chem Biol Interact; 2016 Aug; 256():142-53. PubMed ID: 27417252
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxic effect of peroxisome proliferator fenofibrate on human HepG2 hepatoma cell line and relevant mechanisms.
Jiao HL; Zhao BL
Toxicol Appl Pharmacol; 2002 Dec; 185(3):172-9. PubMed ID: 12498734
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanisms of fenofibrate-induced metabolic catastrophe and glioblastoma cell death.
Wilk A; Wyczechowska D; Zapata A; Dean M; Mullinax J; Marrero L; Parsons C; Peruzzi F; Culicchia F; Ochoa A; Grabacka M; Reiss K
Mol Cell Biol; 2015 Jan; 35(1):182-98. PubMed ID: 25332241
[TBL] [Abstract][Full Text] [Related]
9. Regulation of human apoA-I by gemfibrozil and fenofibrate through selective peroxisome proliferator-activated receptor alpha modulation.
Duez H; Lefebvre B; Poulain P; Torra IP; Percevault F; Luc G; Peters JM; Gonzalez FJ; Gineste R; Helleboid S; Dzavik V; Fruchart JC; Fiévet C; Lefebvre P; Staels B
Arterioscler Thromb Vasc Biol; 2005 Mar; 25(3):585-91. PubMed ID: 15618549
[TBL] [Abstract][Full Text] [Related]
10. Fibrate treatment of eEOCs in murine AKI.
Patschan D; Schwarze K; Henze E; Patschan S; Scheidemann R; Müller GA
J Nephrol; 2014 Feb; 27(1):37-44. PubMed ID: 24430761
[TBL] [Abstract][Full Text] [Related]
11. Vanadium(III)-L-cysteine protects cisplatin-induced nephropathy through activation of Nrf2/HO-1 pathway.
Basu A; Singha Roy S; Bhattacharjee A; Bhuniya A; Baral R; Biswas J; Bhattacharya S
Free Radic Res; 2016; 50(1):39-55. PubMed ID: 26573721
[TBL] [Abstract][Full Text] [Related]
12. No Modifying Effect of Antioxidant N-Acetyl-L-Cysteine on Fenofibrate-induced Hepatocarcinogenesis in Rats.
Nishimura J; Dewa Y; Jin M; Saegusa Y; Kawai M; Kemmochi S; Shimamoto K; Harada T; Itoh T; Shima T; Shibutani M; Mitsumori K
J Toxicol Pathol; 2009 Dec; 22(4):255-61. PubMed ID: 22272000
[TBL] [Abstract][Full Text] [Related]
13. Protective effects of green tea polyphenols on human HepG2 cells against oxidative damage of fenofibrate.
Jiao HL; Ye P; Zhao BL
Free Radic Biol Med; 2003 Nov; 35(9):1121-8. PubMed ID: 14572614
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of in vivo genotoxic potential of fenofibrate in rats subjected to two-week repeated oral administration.
Tawfeeq MM; Suzuki T; Shimamoto K; Hayashi H; Shibutani M; Mitsumori K
Arch Toxicol; 2011 Aug; 85(8):1003-11. PubMed ID: 21127841
[TBL] [Abstract][Full Text] [Related]
15. [Wogonoside reverses cisplatin resistance in SGC7901/cDDP cells through inhibition of PI3K/Akt/Nrf2/ARE signaling pathway].
Wang LJ; Wang SG; Deng TX
Sheng Li Xue Bao; 2018 Aug; 70(4):397-405. PubMed ID: 30112565
[TBL] [Abstract][Full Text] [Related]
16. Potential involvement of PPAR α activation in diminishing the hepatoprotective effect of fenofibrate in NAFLD: Accuracy of non- invasive panel in determining the stage of liver fibrosis in rats.
Hamed AM; El-Kharashi OA; Boctor SS; Abd-Elaziz LF
Biomed Pharmacother; 2017 Jan; 85():68-78. PubMed ID: 27930988
[TBL] [Abstract][Full Text] [Related]
17. Activation of activator protein-1-fibroblast growth factor 21 signaling attenuates Cisplatin hepatotoxicity.
Zhang Y; Le Y; Ji Y; Yarde S; Yu X; Cheng X
Biochem Pharmacol; 2021 Dec; 194():114823. PubMed ID: 34748822
[TBL] [Abstract][Full Text] [Related]
18. Effect and mechanism of peroxisome proliferator-activated receptor-γ on the drug resistance of the U-87 MG/CDDP human malignant glioma cell line.
Han S; Lv X; Wang Y; Gong H; Zhang C; Tong A; Zhang B; Yao H
Mol Med Rep; 2015 Aug; 12(2):2239-46. PubMed ID: 25891367
[TBL] [Abstract][Full Text] [Related]
19. Modulation of fatty acid metabolism is involved in the alleviation of isoproterenol-induced rat heart failure by fenofibrate.
Li P; Luo S; Pan C; Cheng X
Mol Med Rep; 2015 Dec; 12(6):7899-906. PubMed ID: 26497978
[TBL] [Abstract][Full Text] [Related]
20. Ameliorative effect of an oxovanadium (IV) complex against oxidative stress and nephrotoxicity induced by cisplatin.
Basu A; Bhattacharjee A; Hajra S; Samanta A; Bhattacharya S
Redox Rep; 2017 Nov; 22(6):377-387. PubMed ID: 27897082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
